Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis
ObjectiveCholedocholithiasis (CDL) can lead to various complications and requires treatment approaches for both biliary tract clearing and cholecystectomy. This study aims to characterize CDL patients, evaluate treatment strategies, assess associated complications, and explore economic impacts.Metho...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1630416/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850066904331321344 |
|---|---|
| author | Artur Rebelo Marie L. Tischer Jonas Rosendahl Jens Walldorf Tawfik Mosa Jörg Kleeff Johannes Klose |
| author_facet | Artur Rebelo Marie L. Tischer Jonas Rosendahl Jens Walldorf Tawfik Mosa Jörg Kleeff Johannes Klose |
| author_sort | Artur Rebelo |
| collection | DOAJ |
| description | ObjectiveCholedocholithiasis (CDL) can lead to various complications and requires treatment approaches for both biliary tract clearing and cholecystectomy. This study aims to characterize CDL patients, evaluate treatment strategies, assess associated complications, and explore economic impacts.MethodsWe conducted a retrospective analysis of 112 patients between 2016 and 2021 at two centers. We performed a descriptive analysis comparing outcomes of patients undergoing ERCP with and without bile duct stenting. Univariate and multivariable analyses were used to identify factors related to complications.ResultsBile duct stenting was associated with significantly higher complication rates (52.4%) compared to the group without stenting (26.5%) (p = 0.006). Factors influencing stent implantation included prior abdominal surgeries (OR = 03.51, p = 0.02), cholangitis at admission (OR = 03.02, p = 0.032), and bile duct diameter (OR = 01.16, p = 0.057). The overall median length of stay was longer for patients with stenting (19 days) compared to those without (11 days) (p < 0.001). Finally, reimbursements were higher for patients with stenting. Reimbursement for complicated courses was higher than for those without, independent of initial bile duct stenting (with stent p = 0.006, without stent p = 0,003).ConclusionBile duct stenting during CDL management is associated with higher complication rates, longer hospital stay, and increased costs. These associations may reflect both clinical severity at baseline and procedural sequencing. A more restrictive placement of biliary stents might be advisable. |
| format | Article |
| id | doaj-art-a07074dcee674727884e47ed74cfcdec |
| institution | DOAJ |
| issn | 2296-875X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Surgery |
| spelling | doaj-art-a07074dcee674727884e47ed74cfcdec2025-08-20T02:48:34ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-07-011210.3389/fsurg.2025.16304161630416Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysisArtur Rebelo0Marie L. Tischer1Jonas Rosendahl2Jens Walldorf3Tawfik Mosa4Jörg Kleeff5Johannes Klose6Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Internal Medicine-I, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Internal Medicine-I, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Operative Medicine, Carl-von-Basedow-Hospital Saalekreis, Merseburg, GermanyDepartment of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyObjectiveCholedocholithiasis (CDL) can lead to various complications and requires treatment approaches for both biliary tract clearing and cholecystectomy. This study aims to characterize CDL patients, evaluate treatment strategies, assess associated complications, and explore economic impacts.MethodsWe conducted a retrospective analysis of 112 patients between 2016 and 2021 at two centers. We performed a descriptive analysis comparing outcomes of patients undergoing ERCP with and without bile duct stenting. Univariate and multivariable analyses were used to identify factors related to complications.ResultsBile duct stenting was associated with significantly higher complication rates (52.4%) compared to the group without stenting (26.5%) (p = 0.006). Factors influencing stent implantation included prior abdominal surgeries (OR = 03.51, p = 0.02), cholangitis at admission (OR = 03.02, p = 0.032), and bile duct diameter (OR = 01.16, p = 0.057). The overall median length of stay was longer for patients with stenting (19 days) compared to those without (11 days) (p < 0.001). Finally, reimbursements were higher for patients with stenting. Reimbursement for complicated courses was higher than for those without, independent of initial bile duct stenting (with stent p = 0.006, without stent p = 0,003).ConclusionBile duct stenting during CDL management is associated with higher complication rates, longer hospital stay, and increased costs. These associations may reflect both clinical severity at baseline and procedural sequencing. A more restrictive placement of biliary stents might be advisable.https://www.frontiersin.org/articles/10.3389/fsurg.2025.1630416/fullsurgeryERCPcholecysititischolecystectomystent |
| spellingShingle | Artur Rebelo Marie L. Tischer Jonas Rosendahl Jens Walldorf Tawfik Mosa Jörg Kleeff Johannes Klose Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis Frontiers in Surgery surgery ERCP cholecysititis cholecystectomy stent |
| title | Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis |
| title_full | Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis |
| title_fullStr | Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis |
| title_full_unstemmed | Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis |
| title_short | Impact of bile duct stenting on the management of symptomatic choledocholithiasis: a retrospective multicenter analysis |
| title_sort | impact of bile duct stenting on the management of symptomatic choledocholithiasis a retrospective multicenter analysis |
| topic | surgery ERCP cholecysititis cholecystectomy stent |
| url | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1630416/full |
| work_keys_str_mv | AT arturrebelo impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT marieltischer impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT jonasrosendahl impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT jenswalldorf impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT tawfikmosa impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT jorgkleeff impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis AT johannesklose impactofbileductstentingonthemanagementofsymptomaticcholedocholithiasisaretrospectivemulticenteranalysis |